Erratum: Targeting Src in mucinous ovarian carcinoma (Clinical Cancer Research (2021) 17 (5367-5378) DOI: 10.1158/1078-0432.CCR-10-3176)

Koji Matsuo, Masato Nishimura, Justin N. Bottsford-Miller, Jie Huang, Kakajan Komurov, Guillermo N Armaiz Pena, Mian M.K. Shahzad, Rebecca L. Stone, Ju Won Roh, Angela M. Sanguino, Chunhua Lu, Dwight D. Im, Neil B. Rosenshien, Atsuko Sakakibara, Tadayoshi Nagano, Masato Yamasaki, Takayuki Enomoto, Tadashi Kimura, Prahlad T. Ram, Kathleen M. SchmelerGary E Gallick, Kwong K. Wong, Michael Frumovitz, Anil K. Sood

Research output: Contribution to journalComment/debatepeer-review

Abstract

The editors are publishing this note to alert readers to a concern about this article (1): in Fig. 5B, the representative images for the Control and oxaliplatin þ dasatinib panels of CD31 are from the same image file. The authors apologize for this error and stand by the conclusions in the article based on the full dataset.

Original languageEnglish (US)
Pages (from-to)4450
Number of pages1
JournalClinical Cancer Research
Volume27
Issue number15
DOIs
StatePublished - Aug 1 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum: Targeting Src in mucinous ovarian carcinoma (Clinical Cancer Research (2021) 17 (5367-5378) DOI: 10.1158/1078-0432.CCR-10-3176)'. Together they form a unique fingerprint.

Cite this